- Home
- HIX vs TOI Comparison
HIX vs TOI Comparison
Compare HIX & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIX | TOI |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.5M | 327.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HIX | TOI |
|---|---|---|
| Price | $4.25 | $2.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 449.5K | ★ 2.1M |
| Earning Date | 01-01-0001 | 03-23-2026 |
| Dividend Yield | ★ 13.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $25.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $4.16 | $0.60 |
| 52 Week High | $5.08 | $4.88 |
Technical Indicators
Market Signals| Indicator | HIX | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 58.68 | 34.89 |
| Support Level | $4.18 | $2.48 |
| Resistance Level | $4.25 | $2.87 |
| Average True Range (ATR) | 0.03 | 0.22 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 73.91 | 15.81 |
Price Performance
Historical ComparisonAbout HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.